Camilla is currently CEO of Norce, an independent institute in Norway that focuses on research and innovation to address key societal challenges, including those relating to health, society, energy, the environment, and technology. She is educated as a medical doctor and holds a PhD in epidemiology from the University of Oslo; since 2012, she has served as an adjunct professor at the University of Bergen’s Department of Global Public Health and Primary Care. Prof Stoltenberg remains active within research, having led research projects with funding from the EU, The Norwegian Research Council and National Institutes of Health (NIH) in the US.
From 2001, she was part of the top management at the Norwegian Institute of Public Health (NIPH), first as Executive Director of the division of epidemiology, then as a Deputy Director General and from 2012-2023, as Director General. As Director General of NIPH, she was responsible for national strategic projects related to infrastructure for science and analysis. Between 2020-2023, she was NIPH’s spokesperson in the handling of the COVID-19 pandemic.
The last thirty years, she has been strongly engaged in governance and policies for data, national registries, large population-based cohorts, and biobanks, both as sources of health research and more broadly across scientific disciplines, societal sectors, and countries.
